Neurocrine Biosciences

"Patients and family members feel that it’s stigmatizing to have the cognitive impairment of #schizophrenia pointed out to them. That’s not the stigmatizing part. That’s a part of the illness. I think the stigmatizing part is to say ‘well, there’s nothing that we can do about this.’” Watch Dr. Jean-Pierre Lindenmayer and Dr. Richard Keefe discuss cognitive challenges patients with schizophrenia face and the impact it has on their day-to-day lives.

The Huntington's Disease Youth Organization (HDYO) is an international non-profit supporting, educating, and empowering young people impacted by Huntington’s disease (HD). HDYO’s Ambassadors are a group of young people who share their experiences and aim to connect the HD community. Follow along during #HDAwarenessMonth at @HDYOFeed and hdyo.org and #LetsTalkAboutHD.

There are ways to manage uncontrollable body movements. Whether you’re living with tardive dyskinesia (TD) or caring for someone with TD, resources, tips, and other educational content are available to help support you. Click to learn more. #TDAwarenessWeek https://lnkd.in/gyAejaa2

Proactive recognition and treatment of tardive dyskinesia (TD) can make a positive impact in the lives of many people managing their mental illness with antipsychotic medications. That’s why we are committed to working with all segments of the healthcare system – patients, care partners, advocacy organizations, healthcare providers, government and public health officials – to advocate for routine screenings for TD as the standard of care for at-risk patients. Click to read more in the report, sponsored by Neurocrine, from Meadows Mental Health Policy Institute #Screen4TD #TDAwarenessWeek https://lnkd.in/gQcBndcP  

Today we announced the initiation of a Phase 1 clinical study evaluating NBI-1076986, an investigational, oral, M4 subtype-selective muscarinic acetylcholine receptor antagonist. https://lnkd.in/gsD9q4rQ

There are ~600,000 people in the U.S. living with tardive dyskinesia (TD), and ~65% have not yet been diagnosed. Routine screenings are essential for detection, proper diagnosis and appropriate management to help improve therapeutic outcomes. #TDAwarenessWeek https://lnkd.in/gyAejaa2  

Mental health continues to be a significant challenge in the United States, and it is important to include TD in the conversation because of the physical, social and emotional consequences this disorder can have on people trying to maintain mental health stability with antipsychotic medication. Watch two patient advocates share their personal perspectives on the importance of raising #TDAwareness. #TDAwarenessWeek https://lnkd.in/g-atBE4x

We are proud to partner with organizations like Huntington's Disease Society of America year-round, and especially during #HDAwarenessMonth. This May #LetsTalkAboutHD to build awareness and support the #HD community. Visit hdsa.org for more information.

It’s the 7th annual #TDAwarenessWeek, which aims to raise awareness of tardive dyskinesia (TD), a persistent involuntary movement disorder. Join us as we support the ~600,000 people in the U.S. living with TD and access patient & care partner resources: TalkAboutTD.com #Screen4TD

Tardive dyskinesia (TD) is a persistent, involuntary movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso, limbs, and/or fingers or toes. TD is associated with use of antipsychotic medication that may be necessary to treat individuals living with mental illnesses. That’s why #TDAwarenessWeek occurs during #MentalHealthAwarenessMonth, and we’re proud to help educate the community on TD. https://lnkd.in/g-atBE4x